Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 16 Show results per page	View Search Criteria \| Help With Results

Last Modified: 3/27/2007 First Published: 10/1/2001


1.		Phase III Randomized Study of Radiotherapy and Fluorouracil With Either Mitomycin or Cisplatin and With or Without Maintenance Therapy in Patients With Primary Epidermoid Anal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				Not specified				Other				NCRI-ACT-II EU-20056, UKCCCR-ACT-II, ISRCTN26715889, NCT00025090


2.		A Multicenter Trial Comparing Induction C/T Followed by CCRT v.s. CCRT Alone in Stage IV Nasopharyngeal Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				Under 70				Other				T1303 NCT00201396


3.		Trial of Adjuvant Chemotherapy for Gastric Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 to 69				Other				AMC-ONCGI-0102 NCT00296322


4.		Trial of Adjuvant Chemotherapy for Gastric Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 to 69				Other				AMC-ONCGI-0204 NCT00296335


5.		A Prospective,Multi-Center,Randomized Control Trial of Preoperative Hepatic and Regional Arterial Chemotherapy(PHRAC) to Prevent Postoperative Liver Metastasis of Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Approved-not yet active				18 to 74				Other				2008-46 no, NCT00643877


6.		Hyperthermia Treatment in Conjunction With Mitomycin C Versus BCG for Superficial Bladder Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				Not specified				Pharmaceutical / Industry				102.1 NCT00384891

Last Modified: 7/28/2008 First Published: 11/1/2002


7.		Phase II Randomized Study of Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma Receiving Chemoembolization

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				NCI				UCLA-0206060 NCI-G02-2124, NCT00049322


8.		A Phase II Study of Intra-Arterial Chemotherapy With Cisplatin and Mitomycin-C in Patients With Hepatocellular Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Other				3L-03-1 NCT00183885

Last Modified: 6/22/2007 First Published: 1/6/2006


9.		Phase II Study of an Individualized Drug Treatment Selection Process Based on a Tumor Xenograft Model for Patients With Resectable Pancreatic Adenocarcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				NCI				JHOC-J0507 JHOC-05041402, NCT00276744


10.		A Study of Mitomycin C, Irinotecan, and Cetuximab

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				Over 18				Other				UMCC 2005-060 HUM 00000749, NCT00271011

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute